Dieter Cynthia J
Known title: Chief Accounting OfficerCIK: 0001815335
Associated companies
Transaction History
| NEO | ▼ Sell | Tax Withholding | 117 | $0 | 3/2/2023 | View on chart |
| NEO | ▼ Sell | Tax Withholding | 880 | $0 | 3/1/2023 | View on chart |
| NEO | ▼ Sell | Tax Withholding | 959 | $0 | 12/31/2022 | View on chart |
| NEO | ▲ Buy | Grant | 13,141 | $0 | 11/1/2022 | View on chart |
| NEO | ▼ Sell | Tax Withholding | 57 | $0 | 6/22/2022 | View on chart |
| NEO | ▼ Sell | Tax Withholding | 137 | $0 | 3/2/2022 | View on chart |
| NEO | ▲ Buy | Grant | 9,341 | $0 | 3/1/2022 | View on chart |
| NEO | ▲ Buy | Grant | 7,643 | $0 | 12/30/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 13, 2026
NeoGenomics Shares Drop 12% on CEO Transition News
NeoGenomics stock fell 12% following the announcement of a CEO succession plan, despite reporting a revenue beat and a strong Q3 outlook. The market reaction highlights how leadership changes can outweigh immediate financial results. Analysts remain mixed, with StoneX raising its price target to $20 while the average target sits at $21.55.
NeoGenomics Shares Drop 12% on CEO Transition News. NeoGenomics stock fell 12% following the announcement of a CEO succession plan, despite reporting a revenue beat and a strong Q3 outlook. The market reaction highlights how leadership changes can outweigh immediate financial results. Analysts remain mixed, with StoneX raising its price target to $20 while the average target sits at $21.55.